Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation  by Mainz, J.G. et al.
Journal of Cystic Fibrosis 11 (2012) 158–161
www.elsevier.com/locate/jcfCase Studies
Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation
J.G. Mainz a,⁎, J. Hentschel a, C. Schien a, N. Cramer b, W. Pﬁster c, J.F. Beck a, B. Tümmler b
a CF Centre, Pediatric Pneumology, Jena University Hospital, Germany
b Klinische Forschergruppe, Pediatric Pneumology, Med. Hochschule Hannover, Germany
c Microbiology, Jena University Hospital, Germany
Received 11 May 2011; received in revised form 27 October 2011; accepted 28 October 2011
Available online 30 November 2011ABSTRACT
We report on two CF patients who received double lung transplantation (LTX) due to Pseudomonas aeruginosa related pulmonary destruction.
Prior to LTX we detected P. aeruginosa in nasal lavages (NL) and sputum cultures from both patients. Donor lungs of patient 1 became colonized
within four weeks with P. aeruginosa identical in genotype with isolates from his pre-transplant sputum cultures and pre- and post-transplant NL.
In contrast, patient 2 remained P. aeruginosa free in lower airway samples (bronchial lavage/sputum) for now up to 30 months, despite persis-
tent detection of P. aeruginosa that was identical in genotype with pre-transplant NL and sputum isolates in NL and even in throat swabs. For
prevention of pulmonary re-colonization patient 2 has continuously inhaled Colomycin 1 MIU once daily during the preceding more than 36
months with the novel Pari Sinus™ nebulizer, which in scintigraphic studies was shown to deliver vibrating aerosols into paranasal sinuses, ad-
ditional to bronchial antibiotic inhalation.
Discussion: Pulmonary colonization of transplanted donor lungs with identical clones previously colonizing the explanted lungs has been described
previously and the upper airways were postulated as reservoir for descending colonization. However, this remained speculative, as upper airway
sampling which does not belong to current standards, was not performed in these studies.
Our report demonstrates persistence of identical P. aeruginosa genotypes in CF upper airways prior to and after LTX underlining risks of
descending colonization of transplanted lungs with P. aeruginosa, which increases risks of graft dysfunction. Therefore, we recommend regular
assessment of sinonasal colonization prior to and after LTX. Sinonasal inhalation with antimicrobials should be investigated in prospective trials.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; Paranasal sinus; Sinonasal; Pseudomonas aeruginosa; Genotype; Lung transplantation; BOS1. Introduction
1.1. Case reports
Patient 1, a F508del homozygous male, was diagnosed to
suffer from CF by the age of three years because of respiratory
and gastrointestinal symptoms. After the respiratory tract had
become chronically infected with Pseudomonas aeruginosa
about the age of eight years, pulmonary function deteriorated
continuously. Additionally, he had symptoms of chronic⁎ Corresponding author at: Cystic Fibrosis Center, Department of Pediatrics Unive
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doi:10.1016/j.jcf.2011.10.009rhinosinusitis despite sinonasal surgery had been performed
by the age of nine years.
By the age of 20 years a spontaneous pneumothorax oc-
curred which did not stabilize with conventional drainage.
Thoracoscopy was followed by serious complications including
pulmonary leakages, infection and acute respiratory distress
syndrome leading to mechanical ventilation and finally extra-
corporal membrane ventilation (ECMO). After four weeks of
ECMO double lung transplantation was performed. Despite
the need of prolonged intensive treatment including re-operationrsity of Jena, Kochstrasse 2, D 07740 Jena, Germany. Tel.: +49 3641 938 425;
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chotic syndrome the patient recovered considerably well. Pulmo-
nary function improved from FEV 1.1 l (24% predicted) to
presently 3.2 l (71%).
Already during the critical circumstances of post transplant
treatment at the intensive care unit P. aeruginosa was detected
in his BAL fluid samples from the transplanted lungs, which
had not been colonized with the pathogen prior to LTX. The
P. aeruginosa isolates were identical in their multimarker geno-
type [1] with isolates from his explanted lungs and NL sampled
prior and after LTX (Figs. 1a and 2) and the pathogen persisted
despite repeated intravenous antibiotic cycles and oral inhala-
tion of Colomycin.
Patient 2, a F508del homozygous female, was diagnosed to
have CF by the age of five months because of failure to thrive
and recurrent bronchitis. She was fairly stable with CF standard
therapy until an episode of distal intestinal obstruction syn-
drome required surgical intervention by the age of six years.-8 -6 -4 -2 0
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Fig. 1. a and b: Colonization of different airway levels with P. aeruginosa prior and
antipseudomonal agents since 2 months post LTX ( ). (a: patient # 1; b: patien
post LTX periods from each patient were assessed and in each patient they resultedDuring the stay at the hospital the patient acquired a persistent
airway colonization with P. aeruginosa. Despite aggressive
antipseudomonal chemotherapy lung function deteriorated sub-
stantially over the years so that she required double LTX with
resection of the lingula of the donor organ by the age of
20 years. LTX was successful and FEV1 increased from 1.8 l
(30% predicted) to 3.2 l (102%) at present.
P. aeruginosa has not been detected in post-LTX bronch-
eoalveolar lavages or in sputum until now, despite of regular
detection of the pathogen in sinonasal lavages and in three
deep throat swabs (Fig. 1b). For the prevention of the coloniza-
tion of the donor lung with P. aeruginosa from the sinonasal
segment, we instructed the patient to continuously inhale Colo-
mycin 1 MIU twice daily into the lower airways and to admin-
ister Colomycin 1 MIU once daily into the upper airways
(UAW). The utilized device is the Pari Sinus™ nebulizer
which has been shown to deposit vibrating aerosols into the
paranasal sinuses [2,3].2 4 6 8
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Fig. 2. (screenshot): Genotypes of selected indicative P. aeruginosa clones from pre and post LTX periods from patient #1. Identical clones which prior to LTX
colonized the patients' upper and lower airways persisted sinonasally and they colonized the P. aeruginosa free donor lung.
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At our centre the sinonasal UAW segment is sampled by
diagnostic NL from patients elder than 6–8 years [4]. In brief,
10 ml of sterile isotonic saline is applied to each nostril using
a 10 ml syringe, with the head in a slightly reclined position
and the soft palate occluded. After 10 s, nasal fluid is drained
into a sterile cup by anteflection of the head and any material
from the mouth is discarded into a basin.
1.3. Genotyping of P. aeruginosa
P. aeruginosa isolates were typed with a custom-made mi-
croarray as described previously [1]. In brief, DNA amplified
from the bacterial colony by cycles of multiplex primer exten-
sion was hybridized onto the microarray to yield an electroni-
cally portable binary multimarker genotype.
1.4. Sinonasal inhalation
Hitherto, surgical enlargement of sinus orifices was postulat-
ed to permit conventional nebulizers to deliver drugs to the
sinus mucosa, as paranasal sinuses are cavities communicating
with the nose only via narrow ducts [3]. Now, pressure gradi-
ents induced by vibrating air flows were shown to facilitate
deposition of significant amounts of aerosols into sinus cavi-
ties [3] and this principle is implemented in the novel PARI
SINUS™ (Pari Corp, Starnberg, Germany) nebulizer, with a
frequency of approximately 44.5 Hz. Sinonasal inhalation with
the device is performed as described previously [5–7], in
brief, medication is aerosolized into one nostril, while the con-
tralateral nostril is occluded and the soft palate elevated as
recommended for nasal lavage [8]. Study medication is adminis-
tered into both nostrils for 4–6 min each side during arrest of
breathing.
Recently, we assessed the effect of sinonasal inhalation of
dornase alfa delivered with the device compared to placebo ina cross-over pilot study including five CF-patients. We found
that dornase alfa significantly (p=0.043) improves rhinosi-
nusitis related symptoms within the Sino-Nasal Outcome Test-
20 (SNOT-20) [7]. We are performing further investigations
including a further trial with dornase alfa as well as pilot studies
with Tobramycin 80 mg respective Colomycin 1 MIU once
daily with the device. Endpoints of the pilot studies with sinona-
sal nebulization of antibiotics are P. aeruginosa quantification in
nasal lavage fluid of the CF patients who are chronically infected
with the pathogen as well as effects of therapy on disease-
specific, health-related quality-of-life for rhinosinusitis, and
safety and tolerability of the novel therapy.
2. Discussion and conclusions
Pulmonary colonization and infection with P. aeruginosa
remain one major reason for lung deterioration in CF. Addi-
tionally, in patients who successfully underwent lung transplan-
tation, P. aeruginosa colonization of the transplanted organs
was identified as a risk factor to develop the bronchiolitis oblit-
erans syndrome (BOS) that is the major cause for chronic graft
dysfunction [9].
Already in 1997 Walter et al.[10]. found that P. aeruginosa-
free lungs transplanted in CF patients became infected with
P. aeruginosa clones that were identical in genotype with
the isolates from the explanted CF lungs. The authors rea-
soned that colonization occurred from the patients' upper air-
ways and the sinonasal space. However, this conclusion could
not be proven in this and subsequent publications [11–13]
because upper airway sampling had not been performed.
The potential role of the upper airways as the reservoir and
the first site of the colonization of the respiratory tract with
P. aeruginosa has only recently be systematically explored:
First, Krogh Johansen et al. found P. aeruginosa biofilms in
samples taken during sinonasal surgery even if CF patients
had only been intermittently colonized with the pathogen [14].
Second, prospective and non-invasive simultaneous sampling
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revealed that upper and lower airways P. aeruginosa isolates
were identical in genotype in 23 of 24 P. aeruginosa-positive
patients [4]. Co-colonization of the two airway compartments
probably arose from cross-infection. Third, Hansen et al. [15]
recently showed by assessment of intraoperatively taken
material that the paranasal sinuses are a potential niche for
P. aeruginosa clones to adapt and diversify for subsequent
chronic lung infections.
This report proves the persistence of P. aeruginosa in the
UAW and paranasal sinuses in two LTX recipients with CF.
In patient 1 the P. aeruginosa free donor lungs became soon
colonized from this reservoir during prolonged mechanical ven-
tilation and ECMO. In contrast, concomitant sinonasal and
bronchial inhalation of antibiotics appear to have prevented
pulmonary colonization with P. aeruginosa in patient 2. This
novel therapeutic option may be of special interest since
P. aeruginosa colonization of transplanted lungs is a risk factor
to develop BOS. However, longitudinal studies are required to
verify the supposed UAW's role as the site of first infection
and reservoir of colonization of lower CF airways with patho-
gens and prospective trials are needed to assess the potential
of sinonasal inhalation of antimicrobials.Competing interests
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